$10.50+0.06 (+0.57%)
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease.
enVVeno Medical Corporation in the Healthcare sector is trading at $10.50. The stock is currently near its 52-week low of $8.67, remaining 70.5% below its 200-day moving average. Technical signals show neutral RSI of 45 and bearish MACD signal, explaining why NVNO maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company's lead product is the VenoValve, ...
The recent price decline of 22% in enVVeno Medical Corporation's ( NASDAQ:NVNO ) stock may have disappointed insiders...
enVVeno Medical shares plunge after the FDA rejects its VenoValve PMA, citing insufficient trial data and safety concerns tied to the surgical procedure.
Health care stocks rose late Wednesday afternoon, with the NYSE Health Care Index and the Health Car
EnVVeno Medical (NVNO) shares were down 70% in recent Wednesday trading after the company said it re
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...